ISO 31010:2019 - Risk Assessment Techniques Foundation Free Practice Test — 30 Questions

30 questions · Full explanations · No account required

Free
Question 1 of 30

When undertaking a risk assessment for a novel bio-pharmaceutical product undergoing early-stage clinical trials, considering the inherent uncertainties in efficacy, patient response variability, and potential unforeseen side effects, which of the following approaches would most effectively address the qualitative and emergent nature of these risks, aligning with the principles of ISO 31010:2019 for selecting appropriate techniques?

Employing a structured expert judgment technique like a Delphi study or a Scenario Analysis, focusing on eliciting diverse perspectives and exploring potential future states.
Utilizing a purely quantitative Monte Carlo simulation based on historical data from similar, but not identical, drug development programs.
Applying a simple checklist-based assessment derived from generic industry standards without specific adaptation to the unique biological mechanisms of the new compound.
Relying solely on a Fault Tree Analysis (FTA) focused exclusively on mechanical failures within the manufacturing process, ignoring biological and clinical aspects.

About the ISO 31010:2019 - Risk Assessment Techniques Foundation Certification

These free practice questions are designed to help you assess your readiness for the ISO 31010:2019 - Risk Assessment Techniques Foundation exam by ISO. Each question comes with a detailed explanation to reinforce the correct concept. For a complete exam preparation experience with hundreds of questions, spaced-repetition study tools, and full exam simulations, explore our premium access.